Literature DB >> 23519839

The association between the poly(A) polymorphism in the VDR gene and cancer risk: a meta-analysis.

Jin Huang1, Jiqiao Yang, Haichuan Wang, Tianyuan Xiong, Hongbo Zhang, Yaxian Ma, Xiaoze Wang, Jichong Huang, Liang Du.   

Abstract

The poly(A) polymorphism (L/S) in the VDR gene has been implicated in susceptibility of cancer, but a number of studies have reported inconclusive results. The aim of this study is to investigate the relationship between the poly(A) polymorphism in the VDR gene and cancer risk by meta-analysis. We searched PubMed database, EMBASE database, CNKI database, and Wanfang database, covering all studies until January 22, 2013. Statistical analysis was performed by using the software Revman4.2 and STATA 10.0. A total 8,186 cancer cases and 8,685 controls in 19 case-control studies from 15 studies were identified for data analysis. The results suggested that the S allele carriers (SS+SL) did not have an increased or decreased risk of cancer when compared with the homozygote LL carriers (odds ratio (OR) =0.96, 95 % CI=0.87-1.06, P=0.43 for SS+SL vs. LL). In addition, in the subgroup analysis by ethnicity and cancer type, no significant association was found among Caucasians, African-Americans, prostate cancer, or breast cancer. This current meta-analysis suggested that the poly(A) polymorphism in the VDR gene may not contribute to the risk of cancer. Future studies are needed to validate our findings.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23519839     DOI: 10.1007/s13277-013-0724-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

1.  Vitamin d receptor gene variants and esophageal adenocarcinoma risk: a population-based case-control study.

Authors:  C K Chang; H G Mulholland; M M Cantwell; L A Anderson; B T Johnston; A J McKnight; P D Thompson; R G P Watson; L J Murray
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Vitamin D receptor polymorphisms and prostate cancer.

Authors:  D G Blazer; D M Umbach; R M Bostick; J A Taylor
Journal:  Mol Carcinog       Date:  2000-01       Impact factor: 4.784

3.  Vitamin D intake, vitamin D receptor polymorphisms, and breast cancer risk among women living in the southwestern U.S.

Authors:  Dana E Rollison; Ashley L Cole; Ko-Hui Tung; Martha L Slattery; Kathy B Baumgartner; Tim Byers; Roger K Wolff; Anna R Giuliano
Journal:  Breast Cancer Res Treat       Date:  2011-12-01       Impact factor: 4.872

4.  Vitamin D receptor polymorphisms as markers in prostate cancer.

Authors:  L Correa-Cerro; P Berthon; J Häussler; S Bochum; E Drelon; P Mangin; G Fournier; T Paiss; O Cussenot; W Vogel
Journal:  Hum Genet       Date:  1999-09       Impact factor: 4.132

5.  Vascular endothelial growth factor A gene (VEGFA) polymorphisms and expression of VEGFA gene in lung cancer patients of Kashmir Valley (India).

Authors:  Niyaz A Naik; Imtiyaz A Bhat; Dil Afroze; Roohi Rasool; Hyder Mir; Syed Irtiza Andrabi; Sonaullah Shah; Mushtaq A Siddiqi; Zafar A Shah
Journal:  Tumour Biol       Date:  2012-01-10

6.  Associations between androgen and Vitamin D receptor microsatellites and postmenopausal breast cancer.

Authors:  Sara Wedrén; Cecilia Magnusson; Keith Humphreys; Håkan Melhus; Andreas Kindmark; Fredrik Stiger; Maria Branting; Ingemar Persson; John Baron; Elisabete Weiderpass
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-09       Impact factor: 4.254

Review 7.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

8.  Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians.

Authors:  Anurupa Chakraborty; Ashwani K Mishra; Abha Soni; Thodum Regina; R Mohil; D Bhatnagar; A Bhatnagar; Chintamani Chintamani; P C Sharma; Sunita Saxena
Journal:  Cancer Detect Prev       Date:  2009

9.  Risk of early-onset prostate cancer in relation to germ line polymorphisms of the vitamin D receptor.

Authors:  Ingrid Oakley-Girvan; David Feldman; T Ross Eccleshall; Richard P Gallagher; Anna H Wu; Laurence N Kolonel; Jerry Halpern; Raymond R Balise; Dee W West; Ralph S Paffenbarger; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-08       Impact factor: 4.254

10.  Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women.

Authors:  Britton Trabert; Kathleen E Malone; Janet R Daling; David R Doody; Leslie Bernstein; Giske Ursin; Polly A Marchbanks; Brian L Strom; Mariela C Humphrey; Elaine A Ostrander
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  6 in total

1.  The present/null polymorphism in the GSTT1 gene and the risk of lung cancer in Chinese population.

Authors:  Qian Gui; Jianfei Xiong; Changqing Zhu; Xiaoye Lu
Journal:  Tumour Biol       Date:  2013-06-23

2.  The -786T > C polymorphism in the NOS3 gene is associated with increased cancer risk.

Authors:  Yonggang Zhang; Qingyi Jia; Pei Xue; Yuqi Liu; Tianyuan Xiong; Jiqiao Yang; Chenxi Song; Qing He; Liang Du
Journal:  Tumour Biol       Date:  2014-01-24

3.  The Glu298Asp polymorphism in the NOS3 gene and the risk of prostate cancer.

Authors:  Yonggang Zhang; Qingyi Jia; Qing He; Jiani Shen; Jiqiao Yang; Pei Xue; Mengmeng Ma; Rui Xu; Liang Du
Journal:  Tumour Biol       Date:  2014-02-28

4.  Vitamin D receptor gene ApaI polymorphism and breast cancer susceptibility: a meta-analysis.

Authors:  Shayang Luo; Lei Guo; Yan Li; Shouman Wang
Journal:  Tumour Biol       Date:  2013-09-19

5.  Vitamin D receptor rs2228570 polymorphism and susceptibly to ovarian cancer: a meta-analysis.

Authors:  Su Li; Hui Xu; Shuang-Cheng Li; Xiang-Qun Qi; Wen-Juan Sun
Journal:  Tumour Biol       Date:  2013-10-18

6.  Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression.

Authors:  Guoqing Wang; Lei Lei; Xixia Zhao; Jun Zhang; Min Zhou; Kejun Nan
Journal:  Oncol Res       Date:  2014       Impact factor: 5.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.